Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracellular delivery of a phospholamban-targeting aptamer using cardiomyocyte-internalizing aptamers.

European journal of pharmacology·2024
Same author

Postnatal Pdzrn3 deficiency causes acute muscle atrophy without alterations in endplate morphology.

Biochemical and biophysical research communications·2024
Same author

Local immune checkpoint blockade therapy by an adenovirus encoding a novel PD-L1 inhibitory peptide inhibits the growth of colon carcinoma in immunocompetent mice.

Translational oncology·2022
Same author

Calcium/calmodulin-dependent regulation of Rac GTPases and Akt in histamine-induced chemotaxis of mast cells.

Cellular signalling·2021
Same author

PDZRN3 protects against apoptosis in myoblasts by maintaining cyclin A2 expression.

Scientific reports·2020
Same author

Generation of Specific Aptamers.

Methods in molecular biology (Clifton, N.J.)·2018

Related Experiment Video

Updated: Jul 5, 2025

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.4K

Generation of Specific Aptamers.

Shuang Liu1, Yasuyuki Suzuki2, Makoto Inui3

  • 1Department of Pharmacology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan. liussmzk@m.ehime-u.ac.jp.

Methods in Molecular Biology (Clifton, N.J.)
|January 25, 2024
PubMed
Summary
This summary is machine-generated.

Nucleic acid aptamers are short DNA or RNA molecules used as therapeutic agents. The proteoliposome-SELEX method efficiently generates these aptamers for high-affinity binding to targets, offering advantages over antibodies for drug development.

Keywords:
AptamerPCRProteoliposomeSELEXSingle-strand DNA

More Related Videos

Primer-Free Aptamer Selection Using A Random DNA Library
11:14

Primer-Free Aptamer Selection Using A Random DNA Library

Published on: July 26, 2010

24.8K
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.2K

Related Experiment Videos

Last Updated: Jul 5, 2025

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

19.4K
Primer-Free Aptamer Selection Using A Random DNA Library
11:14

Primer-Free Aptamer Selection Using A Random DNA Library

Published on: July 26, 2010

24.8K
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
12:31

A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay

Published on: February 28, 2015

15.2K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Drug Discovery

Background:

  • Nucleic acid aptamers are single-stranded DNA or RNA oligonucleotides.
  • Aptamers exhibit high affinity and specificity for therapeutic targets.
  • They offer advantages over antibodies, including ease of synthesis and modification.

Purpose of the Study:

  • To introduce the proteoliposome-systematic evolution of ligands by exponential enrichment (SELEX) technology.
  • To demonstrate the generation of potential therapeutic agents using this method.

Main Methods:

  • Utilizing a DNA-oligonucleotide pool.
  • Employing the proteoliposome-SELEX technique for ligand selection.

Main Results:

  • The proteoliposome-SELEX method yields aptamers with high affinity and specificity.
  • This technology enables the development of potent therapeutic agents.

Conclusions:

  • Proteoliposome-SELEX is an effective technology for discovering aptamer-based therapeutics.
  • Aptamers represent a promising class of drugs, particularly for conditions like rheumatoid arthritis.